13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001937964-24-000006
Total Value
$366.9M
Positions
45
Other Managers
0
Confidential Omitted
No
Holdings (45)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NOVO-NORDISK A S | NONOF | 741,743 | $88.3M | 24.07% |
| 2 | ELI LILLY & CO | LLY | 92,593 | $82.0M | 22.36% |
| 3 | VIKING THERAPEUTICS INC | VKTX | 532,879 | $33.7M | 9.20% |
| 4 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 216,519 | $15.8M | 4.32% |
| 5 | ASTRAZENECA PLC | AZN | 190,752 | $14.9M | 4.05% |
| 6 | SOLENO THERAPEUTICS INC | SLNO | 274,424 | $13.9M | 3.78% |
| 7 | ELI LILLY & CO | LLY | 15,000 | $13.3M | 3.62% |
| 8 | ALNYLAM PHARMACEUTICALS INC | ALNY | 35,000 | $9.6M | 2.62% |
| 9 | VERTEX PHARMACEUTICALS INC | VRTX | 18,900 | $8.8M | 2.40% |
| 10 | VAXCYTE INC | PCVX | 76,255 | $8.7M | 2.38% |
| 11 | ARGENX SE | ARGX | 15,138 | $8.2M | 2.24% |
| 12 | AXSOME THERAPEUTICS INC | AXSM | 87,848 | $7.9M | 2.15% |
| 13 | PROTAGONIST THERAPEUTICS INC | PTGX | 124,440 | $5.6M | 1.53% |
| 14 | NEUROCRINE BIOSCIENCES INC | NBIX | 45,000 | $5.2M | 1.41% |
| 15 | REVOLUTION MEDICINES INC | RVMDW | 95,885 | $4.3M | 1.19% |
| 16 | DYNE THERAPEUTICS INC | DYN | 119,488 | $4.3M | 1.17% |
| 17 | VERONA PHARMA PLC | 925050106 | 148,590 | $4.3M | 1.17% |
| 18 | MERUS N V | N5749R100 | 80,171 | $4.0M | 1.09% |
| 19 | INSMED INC | INSM | 52,939 | $3.9M | 1.05% |
| 20 | CELLDEX THERAPEUTICS INC NEW | CLDX | 75,300 | $2.6M | 0.70% |
| 21 | CRINETICS PHARMACEUTICALS IN | CRNX | 45,765 | $2.3M | 0.64% |
| 22 | IDEAYA BIOSCIENCES INC | IDYA | 62,992 | $2.0M | 0.54% |
| 23 | MEREO BIOPHARMA GROUP PLC | MREO | 421,359 | $1.7M | 0.47% |
| 24 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 53,930 | $1.7M | 0.47% |
| 25 | NUVALENT INC | NUVL | 15,437 | $1.6M | 0.43% |
| 26 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.6M | 0.43% |
| 27 | CENTESSA PHARMACEUTICALS PLC | CNTA | 80,380 | $1.3M | 0.35% |
| 28 | EYEPOINT PHARMACEUTICALS INC | EYPT | 156,300 | $1.2M | 0.34% |
| 29 | CHARLES RIV LABS INTL INC | 159864107 | 6,305 | $1.2M | 0.34% |
| 30 | IONIS PHARMACEUTICALS INC | IONS | 30,479 | $1.2M | 0.33% |
| 31 | KEROS THERAPEUTICS INC | KROS | 20,000 | $1.2M | 0.32% |
| 32 | KURA ONCOLOGY INC | KURA | 57,178 | $1.1M | 0.30% |
| 33 | ASCENDIS PHARMA A/S | ASND | 7,440 | $1.1M | 0.30% |
| 34 | ANNEXON INC | ANNX | 172,226 | $1.0M | 0.28% |
| 35 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 47,400 | $977,862 | 0.27% |
| 36 | SILENCE THERAPEUTICS PLC | SLNCF | 52,476 | $954,014 | 0.26% |
| 37 | SYNDAX PHARMACEUTICALS INC | SNDX | 48,263 | $929,063 | 0.25% |
| 38 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 54,285 | $901,131 | 0.25% |
| 39 | ALECTOR INC | ALEC | 193,317 | $900,857 | 0.25% |
| 40 | DISC MEDICINE INC | IRON | 13,440 | $660,442 | 0.18% |
| 41 | LARIMAR THERAPEUTICS INC | LRMR | 90,490 | $592,710 | 0.16% |
| 42 | ACELYRIN INC | 00445A100 | 93,114 | $459,052 | 0.13% |
| 43 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,557 | $330,427 | 0.09% |
| 44 | SUMMIT THERAPEUTICS INC | SMMT | 14,512 | $317,813 | 0.09% |
| 45 | Q32 BIO INC | QTTB | 4,705 | $209,937 | 0.06% |